U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 724

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:227963433
GRCh38:
Chr2:227098717
COL4A4G394VAlport syndromeLikely pathogenic
(Apr 5, 2023)
no assertion criteria provided
2.
GRCh37:
ChrX:107911717
GRCh38:
ChrX:108668487
COL4A5G1258VAlport syndromeLikely pathogenic
(May 21, 2020)
criteria provided, single submitter
3.
GRCh37:
Chr2:228122356
GRCh38:
Chr2:227257640
COL4A3, MFF-DTG342DAlport syndromeUncertain significance
(Sep 10, 2019)
criteria provided, single submitter
4.
GRCh37:
ChrX:107938139
GRCh38:
ChrX:108694909
COL4A5Y1597*, Y1603*X-linked Alport syndromePathogenic
(Nov 10, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr2:227906976
GRCh38:
Chr2:227042260
COL4A4not providedLikely benign
(Sep 12, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr2:227958970
GRCh38:
Chr2:227094254
COL4A4G414CAlport syndromeLikely pathogenic
(Nov 13, 2020)
criteria provided, single submitter
7.
GRCh37:
ChrX:107911647
GRCh38:
ChrX:108668417
COL4A5G1235CAlport syndromeLikely pathogenic
(Apr 15, 2021)
criteria provided, single submitter
8.
GRCh37:
ChrX:107824259
GRCh38:
ChrX:108581029
COL4A5Alport syndromePathogenic
(Feb 3, 2021)
criteria provided, single submitter
9.
GRCh37:
ChrX:107909824
GRCh38:
ChrX:108666594
COL4A5G1185RAlport syndromeLikely pathogenic
(Jul 13, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr2:228137829
GRCh38:
Chr2:227273113
COL4A3, MFF-DTE641Dnot providedConflicting interpretations of pathogenicity
(Aug 5, 2022)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr2:227922015
GRCh38:
Chr2:227057299
COL4A4not providedBenign
(Jul 9, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr2:227921977
GRCh38:
Chr2:227057261
COL4A4not providedBenign
(Jul 9, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr2:228154759
GRCh38:
Chr2:227290043
COL4A3, MFF-DTG1009fsnot provided, Alport syndromePathogenic/Likely pathogenic
(Apr 2, 2021)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr2:227896926
GRCh38:
Chr2:227032210
COL4A4P1215Lnot provided, Benign familial hematuria, Autosomal recessive Alport syndrome
Uncertain significance
(May 31, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr2:227915731
GRCh38:
Chr2:227051015
COL4A4R1038Gnot providedUncertain significance
(Apr 10, 2019)
criteria provided, single submitter
16.
GRCh37:
Chr2:228155592
GRCh38:
Chr2:227290876
COL4A3, MFF-DTP1067Lnot provided, Autosomal dominant Alport syndrome, Benign familial hematuria,
Autosomal recessive Alport syndrome
Uncertain significance
(Sep 16, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr2:227968699
GRCh38:
Chr2:227103983
COL4A4K269Enot providedUncertain significance
(Sep 17, 2019)
criteria provided, single submitter
18.
GRCh37:
Chr2:227924210
GRCh38:
Chr2:227059494
COL4A4G765Vnot providedUncertain significance
(Oct 29, 2020)
criteria provided, single submitter
19.
GRCh37:
Chr2:227915806
GRCh38:
Chr2:227051090
COL4A4H1013YInborn genetic diseases, not provided, Benign familial hematuria,
Autosomal recessive Alport syndrome
Uncertain significance
(Feb 22, 2023)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr2:227907835
GRCh38:
Chr2:227043119
COL4A4R1119Gnot providedConflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr2:227887194
GRCh38:
Chr2:227022478
COL4A4not providedLikely benign
(Jan 13, 2019)
criteria provided, single submitter
22.
GRCh37:
Chr2:227915829
GRCh38:
Chr2:227051113
COL4A4G1005EBenign familial hematuria, Autosomal recessive Alport syndrome, not provided
Conflicting interpretations of pathogenicity
(Sep 13, 2022)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr2:227892728-227892729
GRCh38:
Chr2:227028012-227028013
COL4A4not providedBenign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr2:228144567
GRCh38:
Chr2:227279851
COL4A3, MFF-DTnot providedLikely benign
(Apr 16, 2019)
criteria provided, single submitter
25.
GRCh37:
Chr2:227872724-227872725
GRCh38:
Chr2:227008008-227008009
COL4A4not providedLikely benign
(Jun 7, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr2:228137793
GRCh38:
Chr2:227273077
COL4A3, MFF-DTnot providedLikely benign
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr2:228172502
GRCh38:
Chr2:227307786
COL4A3, MFF-DTnot providedLikely benign
(Sep 3, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr2:228115876
GRCh38:
Chr2:227251160
COL4A3, MFF-DTnot providedLikely benign
(Sep 28, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr2:228102686-228102687
GRCh38:
Chr2:227237970-227237971
MFF-DT, COL4A3K34fsAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided
Pathogenic
(Sep 3, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr2:228113209-228113210
GRCh38:
Chr2:227248493-227248494
COL4A3, MFF-DTL175fsnot providedPathogenic
(Sep 20, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr2:228124595
GRCh38:
Chr2:227259879
COL4A3, MFF-DTnot providedLikely pathogenic
(Apr 20, 2021)
criteria provided, single submitter
32.
GRCh37:
ChrX:107920819
GRCh38:
ChrX:108677589
COL4A5G1294S, G1300SAlport syndrome, not providedLikely pathogenic
(Feb 2, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr2:227976431
GRCh38:
Chr2:227111715
COL4A4Autosomal recessive Alport syndrome, Benign familial hematuria, COL4A4-related condition,
not provided
Likely pathogenic
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr17:18055457
GRCh38:
Chr17:18152143
MYO15AP2642Lnot provided, Alport syndromeUncertain significance
(Mar 18, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr21:37833945
GRCh38:
Chr21:36461647
CLDN14, CLDN14-AS1G17SAlport syndromeUncertain significance
(Apr 12, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr2:228109668
GRCh38:
Chr2:227244952
COL4A3, MFF-DTG94Anot providedUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
37.
GRCh37:
Chr2:227974009
GRCh38:
Chr2:227109293
COL4A4Autosomal recessive Alport syndrome, Benign familial hematuria, not provided
Uncertain significance
(Sep 8, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr2:227872849
GRCh38:
Chr2:227008133
COL4A4R1565Hnot providedUncertain significance
(Nov 17, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr2:228109073
GRCh38:
Chr2:227244357
COL4A3, MFF-DTG91Dnot providedPathogenic/Likely pathogenic
(Dec 14, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr2:228173942
GRCh38:
Chr2:227309226
COL4A3, MFF-DTA1555Tnot providedUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr2:228175517
GRCh38:
Chr2:227310801
COL4A3, MFF-DTT1594Snot providedUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr2:228173943
GRCh38:
Chr2:227309227
COL4A3, MFF-DTA1555Vnot providedConflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
43.
GRCh37:
Chr2:227886889
GRCh38:
Chr2:227022173
COL4A4G1364Vnot providedUncertain significance
(Dec 19, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr2:228172428
GRCh38:
Chr2:227307712
COL4A3, MFF-DTP1419Tnot providedUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr2:227906935
GRCh38:
Chr2:227042219
COL4A4G1145Enot providedUncertain significance
(Sep 2, 2021)
criteria provided, single submitter
46.
GRCh37:
Chr2:227967860
GRCh38:
Chr2:227103144
COL4A4not providedUncertain significance
(Sep 2, 2021)
criteria provided, single submitter
47.
GRCh37:
Chr2:227924118
GRCh38:
Chr2:227059402
COL4A4not providedUncertain significance
(Oct 24, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr2:227924893
GRCh38:
Chr2:227060177
COL4A4R708Inot providedConflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
49.
GRCh37:
Chr2:228118051
GRCh38:
Chr2:227253335
COL4A3, MFF-DTR229Wnot providedUncertain significance
(Jan 8, 2023)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr2:228155508
GRCh38:
Chr2:227290792
COL4A3, MFF-DTG1039Enot providedUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
51.
GRCh37:
Chr2:227953528
GRCh38:
Chr2:227088812
COL4A4N488Knot provided, Autosomal recessive Alport syndrome, Benign familial hematuria
Uncertain significance
(Sep 27, 2023)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr2:228173922
GRCh38:
Chr2:227309206
COL4A3, MFF-DTC1548Ynot providedUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
53.
GRCh37:
Chr2:227953521
GRCh38:
Chr2:227088805
COL4A4L491FAutosomal recessive Alport syndrome, Benign familial hematuria, not provided
Conflicting interpretations of pathogenicity
(Oct 3, 2022)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr2:228113217
GRCh38:
Chr2:227248501
COL4A3, MFF-DTP176Rnot provided, not specifiedUncertain significance
(Feb 15, 2023)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr2:227924959
GRCh38:
Chr2:227060243
COL4A4G686Dnot providedUncertain significance
(Aug 13, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr2:228029505
GRCh38:
Chr2:227164789
COL4A3, LOC129935730not providedLikely benign
(Sep 26, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr2:227967570
GRCh38:
Chr2:227102854
COL4A4not providedLikely benign
(Sep 16, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr2:227920766
GRCh38:
Chr2:227056050
COL4A4L871Fnot providedUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
59.
GRCh37:
Chr2:227973298
GRCh38:
Chr2:227108582
COL4A4P245Lnot provided, Autosomal recessive Alport syndrome, Benign familial hematuria
Uncertain significance
(Mar 14, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr2:228004877
GRCh38:
Chr2:227140161
COL4A4not providedPathogenic
(Oct 9, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr2:227896707
GRCh38:
Chr2:227031991
COL4A4not providedConflicting interpretations of pathogenicity
(Aug 5, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr2:228175501
GRCh38:
Chr2:227310785
COL4A3, MFF-DTA1589TAlport syndromeUncertain significance
(Aug 13, 2020)
no assertion criteria provided
63.
GRCh37:
Chr2:228172623
GRCh38:
Chr2:227307907
COL4A3, MFF-DTG1484RAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
Inborn genetic diseases
Uncertain significance
(Dec 28, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr2:228163503
GRCh38:
Chr2:227298787
COL4A3, MFF-DTG1286VAlport syndromeUncertain significance
(Aug 13, 2020)
no assertion criteria provided
65.
GRCh37:
Chr2:228163410
GRCh38:
Chr2:227298694
COL4A3, MFF-DTP1255HAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided
Conflicting interpretations of pathogenicity
(Sep 9, 2022)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr2:228162559
GRCh38:
Chr2:227297843
COL4A3, MFF-DTAlport syndromeUncertain significance
(Aug 13, 2020)
no assertion criteria provided
67.
GRCh37:
Chr2:228157950
GRCh38:
Chr2:227293234
COL4A3, MFF-DTM1085RAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided
Uncertain significance
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr2:228135637
GRCh38:
Chr2:227270921
COL4A3, MFF-DTV576AAlport syndromeUncertain significance
(Aug 13, 2020)
no assertion criteria provided
69.
GRCh37:
Chr2:228128512
GRCh38:
Chr2:227263796
COL4A3, MFF-DTnot providedLikely benign
(Dec 17, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr2:228121089
GRCh38:
Chr2:227256373
COL4A3, MFF-DTAutosomal dominant Alport syndrome, Autosomal recessive Alport syndrome, Benign familial hematuria,
not provided
Likely benign
(Aug 25, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr2:228118034
GRCh38:
Chr2:227253318
COL4A3, MFF-DTI223TAlport syndromeUncertain significance
(Nov 5, 2020)
no assertion criteria provided
72.
GRCh37:
Chr2:227985825
GRCh38:
Chr2:227121109
COL4A4P78SBenign familial hematuria, Autosomal recessive Alport syndrome, not provided
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr2:227968738
GRCh38:
Chr2:227104022
COL4A4P256SAlport syndromeUncertain significance
(Aug 14, 2020)
no assertion criteria provided
74.
GRCh37:
Chr2:227967884
GRCh38:
Chr2:227103168
COL4A4Alport syndromeUncertain significance
(Aug 13, 2020)
no assertion criteria provided
75.
GRCh37:
Chr2:227967883
GRCh38:
Chr2:227103167
COL4A4L283MAlport syndromeUncertain significance
(Aug 13, 2020)
no assertion criteria provided
76.
GRCh37:
Chr2:227953407
GRCh38:
Chr2:227088691
COL4A4P529SAlport syndromeUncertain significance
(Aug 15, 2020)
no assertion criteria provided
77.
GRCh37:
Chr2:227896874
GRCh38:
Chr2:227032158
COL4A4Alport syndromeUncertain significance
(Sep 4, 2020)
no assertion criteria provided
78.
GRCh37:
Chr2:227886885
GRCh38:
Chr2:227022169
COL4A4Alport syndromeUncertain significance
(Aug 13, 2020)
no assertion criteria provided
79.
GRCh37:
Chr2:227872285
GRCh38:
Chr2:227007569
COL4A4Q1610RAlport syndromeUncertain significance
(Aug 14, 2020)
no assertion criteria provided
80.
GRCh37:
ChrX:107814695-107814696
GRCh38:
ChrX:108571465-108571466
COL4A5Alport syndromeLikely pathogenic
(Dec 11, 2016)
no assertion criteria provided
81.
GRCh37:
ChrX:107910365
GRCh38:
ChrX:108667135
COL4A5Q1186*Alport syndromePathogenic
(Oct 25, 2018)
no assertion criteria provided
82.
GRCh37:
ChrX:107938099
GRCh38:
ChrX:108694869
COL4A5P1584H, P1590HAlport syndromePathogenic
(Oct 24, 2018)
no assertion criteria provided
83.
GRCh37:
ChrX:107850056
GRCh38:
ChrX:108606826
COL4A5R777Cnot providedLikely benign
(Mar 25, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr2:228172635
GRCh38:
Chr2:227307919
COL4A3, MFF-DTG1488RAlport syndromeUncertain significance
(Oct 24, 2018)
no assertion criteria provided
85.
GRCh37:
ChrX:107930767-107930768
GRCh38:
ChrX:108687537-108687538
COL4A5G1454fs, G1460fsAlport syndromePathogenic
(Oct 24, 2018)
no assertion criteria provided
86.
GRCh37:
ChrX:107840780-107840799
GRCh38:
ChrX:108597550-108597569
COL4A5Alport syndromePathogenic
(Oct 24, 2018)
no assertion criteria provided
87.
GRCh37:
ChrX:107814692
GRCh38:
ChrX:108571462
COL4A5P145LAlport syndromeUncertain significance
(Jan 9, 2018)
no assertion criteria provided
88.
GRCh37:
ChrX:107908736
GRCh38:
ChrX:108665506
COL4A5Alport syndromePathogenic
(Jun 1, 2018)
no assertion criteria provided
89.
GRCh37:
Chr2:227886782
GRCh38:
Chr2:227022066
COL4A4R1400Gnot providedLikely benign
(Aug 15, 2022)
criteria provided, single submitter
90.
GRCh37:
ChrX:107865033
GRCh38:
ChrX:108621803
COL4A5G893AAlport syndromePathogenic
(Oct 24, 2018)
no assertion criteria provided
91.
GRCh37:
ChrX:107920804
GRCh38:
ChrX:108677574
COL4A5Q1289*, Q1295*Alport syndromePathogenic
(Dec 6, 2019)
no assertion criteria provided
92.
GRCh37:
ChrX:107845202
GRCh38:
ChrX:108601972
COL4A5G710EAlport syndromeLikely pathogenic
(Oct 24, 2019)
no assertion criteria provided
93.
GRCh37:
ChrX:107840241
GRCh38:
ChrX:108597011
COL4A5P511fsAlport syndromeLikely pathogenic
(Aug 16, 2019)
no assertion criteria provided
94.
GRCh37:
ChrX:107845113
GRCh38:
ChrX:108601883
COL4A5Alport syndromeLikely pathogenic
(Jan 28, 2020)
no assertion criteria provided
95.
GRCh37:
ChrX:107829842
GRCh38:
ChrX:108586612
COL4A5not providedUncertain significance
(Dec 18, 2020)
criteria provided, single submitter
96.
GRCh37:
ChrX:107939606
GRCh38:
ChrX:108696376
COL4A5Alport syndromeUncertain significance
(Apr 3, 2018)
no assertion criteria provided
97.
GRCh37:
Chr2:227919418
GRCh38:
Chr2:227054702
COL4A4G918Rnot provided, Autosomal recessive Alport syndromeConflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
ChrX:107840236
GRCh38:
ChrX:108597006
COL4A5G509Rnot provided, X-linked Alport syndromeLikely pathogenic
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
ChrX:107929335-107929341
GRCh38:
ChrX:108686105-108686111
COL4A5D1425fs, D1431fsAlport syndromeLikely pathogenic
(May 31, 2018)
no assertion criteria provided
100.
GRCh37:
ChrX:107807157-107807158
GRCh38:
ChrX:108563927-108563928
COL4A5Alport syndromeLikely pathogenic
(Aug 27, 2018)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination